Fabiola Martin

Summary

Affiliation: Hull York Medical School
Country: UK

Publications

  1. doi request reprint Two cases of possible transmitted drug-resistant HIV: likely HIV superinfection and unmasking of pre-existing resistance
    Fabiola Martin
    Centre for Immunology and Infection, Department of Biology, University of York, York, UK
    Int J STD AIDS 27:66-9. 2016
  2. pmc Conference highlights of the 16th International Conference on Human Retrovirology: HTLV and related retroviruses, 26-30 June 2013, Montreal, Canada
    Benoit Barbeau
    D├ępartement des Sciences Biologiques and BioMed Research Center, Universite du Quebec a Montreal, Room SB 3335, 2080 St Urbain, Montreal, Quebec, Canada
    Retrovirology 11:19. 2014
  3. pmc Ciclosporin A proof of concept study in patients with active, progressive HTLV-1 associated myelopathy/tropical spastic paraparesis
    Fabiola Martin
    Centre for Immunology and Infection, Department of Biology, Hull and York Medical School, University of York, York, United Kingdom
    PLoS Negl Trop Dis 6:e1675. 2012
  4. pmc Conference highlights of the 15th International Conference on Human Retrovirology: HTLV and related retroviruses, 4-8 June 2011, Leuven, Gembloux, Belgium
    Fabiola Martin
    Centre for Immunology and Infection, Department of Biology, Hull and York Medical School, University of York, York, UK
    Retrovirology 8:86. 2011

Collaborators

  • Benoit Barbeau
  • Edgar Carvalho
  • John Hiscott
  • William M Switzer
  • Edward L Murphy
  • Masao Matsuoka
  • Kathryn Jones
  • Ali Bazarbachi
  • Toshiki Watanabe
  • Lee Ratner

Detail Information

Publications4

  1. doi request reprint Two cases of possible transmitted drug-resistant HIV: likely HIV superinfection and unmasking of pre-existing resistance
    Fabiola Martin
    Centre for Immunology and Infection, Department of Biology, University of York, York, UK
    Int J STD AIDS 27:66-9. 2016
    ..The second patient was a case of the emergence of primary resistant virus under drug pressure. Both suppressed their virus promptly after treatment switch. ..
  2. pmc Conference highlights of the 16th International Conference on Human Retrovirology: HTLV and related retroviruses, 26-30 June 2013, Montreal, Canada
    Benoit Barbeau
    D├ępartement des Sciences Biologiques and BioMed Research Center, Universite du Quebec a Montreal, Room SB 3335, 2080 St Urbain, Montreal, Quebec, Canada
    Retrovirology 11:19. 2014
    ..In this review, highlights of the meeting are provided by different experts for each of these research areas. ..
  3. pmc Ciclosporin A proof of concept study in patients with active, progressive HTLV-1 associated myelopathy/tropical spastic paraparesis
    Fabiola Martin
    Centre for Immunology and Infection, Department of Biology, Hull and York Medical School, University of York, York, United Kingdom
    PLoS Negl Trop Dis 6:e1675. 2012
    ..We therefore tested the hypothesis that inhibition of T-cell activation with ciclosporin A would be safe and clinically beneficial in patients with early and/or clinically progressing HAM/TSP...
  4. pmc Conference highlights of the 15th International Conference on Human Retrovirology: HTLV and related retroviruses, 4-8 June 2011, Leuven, Gembloux, Belgium
    Fabiola Martin
    Centre for Immunology and Infection, Department of Biology, Hull and York Medical School, University of York, York, UK
    Retrovirology 8:86. 2011
    ....